Development of hyperbilirubinemia in BMT recipients. Bilirubin levels (mean ± SD) were significantly elevated (*P < .05) in patients with (▪) VOD (n = 7) as compared with patients with (▴) GVHD (n = 7) or (▾) other liver damage (n = 17)